News
Harvard Medical School Cancels Student Groups’ Pro-Palestine Vigil
News
Former FTC Chair Lina Khan Urges Democrats to Rethink Federal Agency Function at IOP Forum
News
Cyanobacteria Advisory Expected To Lift Before Head of the Charles Regatta
News
After QuOffice’s Closure, Its Staff Are No Longer Confidential Resources for Students Reporting Sexual Misconduct
News
Harvard Still On Track To Reach Fossil Fuel-Neutral Status by 2026, Sustainability Report Finds
To the Editors:
I find it most disappointing that your paper has yet to review the production of Caryl Churchill's "Cloud 9" that is presently playing at the Loeb Experimental Theater in Cambridge. Since your paper has reviewed other, far less professional productions by the Harvard Summer Theater Program such as a recent production of "The Bathtub," I find it inexplicable that you have overlooked this wonderful piece of theater. "Cloud 9" is not only an entertaining play; it is an important play as well. Churchill's feminist representation of gender roles and the politics of sex is just as relevant to the greater Boston area in 1992 as it was in 1979 England.
Why is it, then, that your paper has overlooked a production that everybody should see, when in the past you have been not the least bit reluctant to review productions that lack any semblance of artistic or political merit? Your failure to print a review of this feminist play suggests a patriarchal, rather conservative political agenda and a stubborn unwillingness to approach the theater with an open mind.
As a long-time reader, I sincerely hope that this is not the case. I strongly urge you to give this excellent production its fair share of press. It is high time that all publications realize that progress will never be made on issues of gender relations as long as attention is devoted exclusively to conventional drama at the expense of productions like "Cloud 9" that raise important questions without going overboard with excessive radical feminist rhetoric.
Want to keep up with breaking news? Subscribe to our email newsletter.